Representative Jefferson Shreve (R-Indiana) recently bought shares of Pfizer Inc. (NYSE:PFE). In a filing disclosed on March ...

Migraine disrupts daily life with invisible neurological pain, causing physical, emotional, and cognitive struggles that go ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Calcitonin gene-related peptide (CGRP) antagonists: These include Ubrelvy (ubrogepant), Nurtec ODT (rimegepant), Zavzpret (zavegepant), and may be used to treat acute migraine with brainstem aura.

NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at TD Cowen’s 45 th Annual Health Care Conference on March 4, ...

The pharmaceutical industry is evolving continuously with the advancements in drug discovery with Artificial Intelligence (AI), propelling the industry’s growth. Amid this backdrop, quality medical ...

Pfizer’s Nurtec ODT, and others. The company delivered $2.8 billion in Portfolio Receipts for fiscal year 2024, at the high end of its guidance range. This reflects a 13% growth, significantly ...

to health care providers to induce them to prescribe Nurtec ODT (Nurtec), a prescription medication for the treatment of migraine headaches. As part of the settlement, the State of Michigan will ...

Ubrelvy (ubrogepant) and Nurtec ODT (rimegepant) are brand-name oral tablets. They’re both prescribed for treating migraine in adults. This article explains the main similarities and differences ...